Market revenue in 2023 | USD 498.1 million |
Market revenue in 2030 | USD 905.2 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | In house |
Fastest growing segment | Contract Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In House, Contract Outsourcing |
Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 60.99% in 2023. Horizon Databook has segmented the India veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The veterinary API manufacturing market in India is expected to grow unprecedentedly over the forecast period. Growth in the country can be attributed to the increased government efforts to drive veterinary healthcare facilities and numerous funding schemes by state & national agencies.
As per the Government of India’s Open Government Data Platform, India had roughly 12,000 veterinary hospitals and polyclinics in 2021. The states of Rajasthan, Uttar Pradesh, and Punjab collectively accounted for over 50% of the country’s veterinary hospitals and polyclinics.
The government is providing funds to establish & strengthen existing veterinary hospitals and dispensaries, creating growth opportunities in India. Furthermore, key players are adopting numerous strategies, such as acquisitions, partnerships, product launches, and business developments, which is expected to drive market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the India veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into India veterinary active pharmaceutical ingredients manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account